In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 2, 1996, Pages 134-145

  Hoch, Robert C ^a   Schraufstätter, Ingrid U ^b   Cochrane, Charles G ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030204636     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90005-0     Document Type: Review

References (97)

1. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673-9.
2. Sticherling M, Bornscheuer E, Schröder J-M, Christophers E. Localization of neutrophil-activating peptide-1/interleukin-8 immunoreactivity in normal and psoriatic skin. J Invest Derm 1991;96:26-30.
3. Seitz M, Dewald B, Gerber N, Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest 1991;87:463-9.
4. Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991;34:894-903.
5. Hoch RC, Rodriguez R, Manning T, Bishop M, Mead P, Shoemaker WC, et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993;21:839-45.
6. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108:636-41.
7. Raijmakers PGHM, Groeneveld ABJ, Rauwerda JA, Schneider AJ, Teule GJJ, et al. Transient increase in interleukin-8 and pulmonary microvascular permeability following aortic surgery. Am J Respir Crit Care Med 1995;151:698-705.
8. Car BD, Meloni F, Liusetti M, Semenzato G, Gialdroni-Grassi G, Walz A. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:655-9.
9. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophagecolony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1991;89:1001-9.
10. Broaddus VC, Hébert CA, Vitangcol RV, Hoeffel JM, Bernstein MS, Boylan AM. Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis 1992;146:825-30.
11. Benfield TL, Vestbo J, Junge J, Nielsen TL, Jensen AB, Lundgren JD. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1995;151:1058-62.
12. Donnelly SC, Stricter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993;341:643-7.
13. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992;146:427-32.
14. Matsushima K, Baldwin E, Mukaida N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem Immunol 1992;51:236-65.
15. Zwahlen R, Walz A, Rot A. In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int Rev Exp Pathol 1993;34B:27-42.
16. Hébert C, Baker J. Interleukin-8: a review. Cancer Invest 1993;11:743-50.
17. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988;167:1547-59.
18. Thelen M, Peveri P, Kernen P, Von Tscharner V, Walz A, Baggiolini M. Mechanism of action of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 1988;2:2702-6.
19. Detmers P, Powell D, Walz A, Clark-Lewis I, Baggiolini M, Cohn ZA. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol 1991;147:4211-7.
20. Luscinskas FW, Kiely JM, Ding H, Obin MS, Hébert CA, Baker JB, et al. In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J Immunol 1992;149:2163-71.
21. Holmes W, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science 1991;253:1278-80.
22. Murphy P, Tiffany H. Cloning of a complementary DNA encoding a functional human interleukin-8 receptor. Science 1991;253:1280-3.
23. Ahuja SK, Lee JC, Murphy PM. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. J Biol Chem 1996;271: 225-32.
24. Hammond M, Lapointe G, Feucht P, Hilt S, Gallegos C, Gordon C, et al. IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors. J Immunol 1995;155:1428-33.
25. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B. Both interleukin-8 receptors independently mediate chemotaxis. Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GROα and NAP-2. FEBS Lett 1994;341: 187-92.
26. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide(LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin-1 (IL 1). J Immunol 1987;139:788-93.
27. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lee W, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988;167:1883-93.
28. Schroeder J-M, Mrowietz U, Christophers E. Purification and partial biological characterization of a human lymphocyte derived peptide with potent neutrophil stimulation activity. J Immunol 1988;140:3534-40.
29. Larsen CG, Anderson AP, Oppenheim JJ, Matusushima K. Production of interleukin 8 by human dermal fibroblasts and keratinocytes in response to interleukin 1 or tumor necrosis factor. Immunology 1989;68:31-6.
30. Sica A, Matsushima K, Wang JM, Polentarutti N, Dejena E, Colotta F, et al. IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology 1990;69:548-53.
31. Einer VM, Strieter RM, Einer SG, Baggiolini M, Lindley I, Kunkel SL. Neutrophil chemotactic factor (IL-8) gene expresion by cytokine-treated retinal pigment epithelial cells. Am J Pathol 1990;136:745-50.
32. Thornton AJ, Strieter RM, Lindley I, Baggiolini M, Kunkel SL. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J Immunol 1989; 144:2609-13.
33. Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, et al. Synovial tissue macrophages as a source of the chemotactic cytokine IL-8. J Immunol 1991;147:2187-95.
34. Standiford TJ, Kunkel SJ, Basha MA, Chensue SW, Lynch JP, Toews GB, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J Clin Invest 1990;86:1945-53.
35. Recklies AD, Golds EE. Induction of synthesis and release of interleukin-8 from human articular chondrocytes and cartilage explants. Arthritis Rheum 1992;35:1510-9.
36. Kusner DJ, Luebbers EL, Nowinski RJ, Konieczkowski M, King CH, Sedor JR. Cytokine- and LPS-induced synthesis of interleukin-8 from human mesangial cells. Kidney Int 1991; 39:1240-8.
37. Yoshimura T, Robinson EA, Appella E, Matusushima K, Showalter SD, Skeel A, et al. Three forms of monocytederived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. Mol Immunol 1989;26:87-93.
38. Van Damme J, Van Beeumen J, Conings R, Decock B, Billiau A. Purification of granulocyte chemotactic peptide/ interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin. Eur J Biochem 1989; 181:337-4.
39. Hébert CA, Luscinskas FW, Kiely JM, Luis EA, Darbonne WC, Bennett GL, et al. Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J Immunol 1990;145:3033-40.
40. Streiter RM, Kasahara K, Allen RM, Standiford TJ, Rolfe MW, Becker FS, et al. Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 1992;141:397-407.
41. Takahashi GW, Andrews DF, Lilly MB, Singer JW, Alderson MR. Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. Blood 1993;81:357-64.
42. McCain RW, Holden EP, Blackwell TR, Christman JW. Leukotriene B4 stimulates human polymorphonuclear leukocytes to synthesize and release interleukin-8 in vitro. Am J Respir Cell Mol Biol 1994;10:651-7.
43. Baldwin ET, Weber IT, St. Charles R, Xuan JC, Appella E, Yamada M, et al. Crystal structure of interleukin-8: symbiosis of NMR and crystallography. Proc Natl Acad Sci USA 1991; 88:502-6.
44. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM. Three dimensional structure of interleukin-8 in solution. Biochem 1990;29:1689-96.
45. Paolini JF, Willard D, Consler T, Luther M, Krangel MS. The chemokines IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations. J Immunol 1994;153:2704-17.
46. Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, et al. Neutrophil activation by monomeric interleukin-8. Science 1994;264:90-2.
47. Colditz I, Zwahlen R, Dewald B, Baggiolini M. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am J Pathol 1989;134:755-60.
48. Rot A. Some aspects of NAP-1 pathophysiology: lung damage caused by a blood-borne cytokine. Adv Exp Med Biol 1991;305:127-35.
49. Matsukawa A, Yoshimura T, Maeda T, Ohkawara S, Katsumasa T, Yoshinaga M. Neutrophil accumulation and activation by homologous IL-8 in rabbits. J Immunol 1995;154: 5418-25.
50. Akahoshi Y, Endo H, Kondo H, Kashiwazaki S, Kasahara T, Mukaida N, et al. Essential involvement of interleukin 8 in neutrophil recruitment in rabbit with acute experimental arthritis induced by lipopolysaccharide and interleukin 1. Lymphokine Cytokine Res 1993;13:113-6.
51. Broaddus VC, Boylan AM, Hoeffel JM, Kim KJ, Sadick M, Chuntharapai A, et al. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol 1994;152:2960-7.
52. Wada T, Tomosugi N, Naito T, Yokoyama H, Kobyashi K, Harada A, et al. Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis. J Exp Med 1994;180:1135-40.
53. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993;365:654-7.
54. Mulligan MS, Jones ML, Bolanowski MA, Baganoff MP, Deppeler CL, Meyers DM, et al. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 1993;150:5585-95.
55. Folkesson HG, Matthay MA, Hébert CA, Broaddus VC. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 1995;96: 107-16.
56. Kutkoski GJ, Broaddus VC, Hébert C, Doerschuk CM. The effect of anti-IL-8 antibodies on the clearance of S. pneumoniae from the lungs. Am J Respir Crit Care Med 1995; 151:A599.
57. Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, et al. Neutrophil and B-cell expansion in mice that lack the murine IL-8 receptor homolog. Science 1994;265: 682-4.
58. Hébert CA, Vitangcol RV, Baker JB. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem 1991;266:18989-94.
59. 15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A. J Biol Chem 1995;270:10428-31.
60. Schraufstätter IU, Barritt DS, Ma M, Oades Z, Cochrane CG. Multiple sites on IL-8 responsible for binding to α and β IL-8 receptors. J Immunol 1993;151:6418-28.
61. Heinrich JN, Bravo R. The orphan mouse receptor interleukin (IL)-8Rβ binds N51. J Biol Chem 1995;270:4987-9.
62. LaRosa GJ, Thomas KM, Kaufmann ME, Mark R, White M, Taylor L, et al. Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem 1992;267:25402-6.
63. Hébert CA, Chuntharapai A, Smith M, Colby T, Kim J, Horuk R. Partial functional mapping of the human interleukin-8 type A receptor. J Biol Chem 1993;268:18549-53.
64. Leong SR, Kabakoff RC, Hébert CA. Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction. J Biol Chem 1994;269:19343-8.
65. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 1992;11:1-20.
66. 2-terminal region of the receptor. J Immunol 1994;152:1783-9.
67. Norgauer J, Metzner B, Schraufstätter IU. Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells. J Immunol 1996;156:1132-7.
68. Kuijpers TW, Hakkert BC, Hart MHL, Roos D. Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol 1992;117:565-72.
69. Huber AR, Kunkel SL, Todd R, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991;254:99-102.
70. Smith WB, Gamble JR, Clark-Lewis I, Vadas MA. Interleukin-8 induces neutrophil transendothelial migration. Immunology 1991;72:65-72.
71. Gimbrone MA, Obin MS, Brouck AF, Luis EA, Hass PE, Hébert CA, et al. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 1989;246:1601-3.
72. Hechtman DH, Cybulsky MI, Fuchs HJ, Baker JB, Gimbrone MA. Intravascular IL-8: inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 1991;147:883-92.
73. Ley K, Baker JB, Cybulsky MI, Gimbrone MA, Luscinskas FW. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J Immunol 1993;151:6347-57.
74. Simonet WS, Hughes TM, Nguyen HQ, Trebasky LD, Danilenko DM, Medlock ES. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest 1994;94:1310-9.
75. Rot A. Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism. Eur J Immunol 1993;23:303-6.
76. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 1992;13:291-4.
77. Webb LMC, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 1993;90:7158-62.
78. Smart SJ, Casale TB. Interleukin-8-induced transcellular neutrophil migration is facilitated by endothelial and pulmonary epithelial cells. Am J Respir Cell Mol Biol 1993;9:489-95.
79. Wen D, Rowland A, Derynck R. Expression and secretion of gro/MGSA by stimulated human endothelial cells. EMBO J 1989;8:1761-6.
80. Biffl WL, Moore EE, Moore FA, Carl VS, Franciose RJ, Banerjee A. Interleukin-8 increases endothelial permeability independent of neutrophils. J Trauma 1995;39:98-102.
81. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-801.
82. Schönbeck U, Brandt E, Petersen F, Flad H-D, Loppnow H. IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 1995;154:2375-83.
83. Petzelbauer P, Watson CA, Pfau SE, Pober JS. IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995; 7:267-72.
84. Watson CA, Camera-Benson L, Palmer-Crocker R, Pober JS. Variability among human umbilical vein endothelial cell cultures. Science 1995;268:447-8.
85. Cutbush M, Mollison PL, Parkin DM. A new human blood group. Nature 1950;165:188-9.
86. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks: the Duffy-blood-group genotype, FyFy. N Engl J Med 1976;295:302-4.
87. Darbonne WC, Rice GC, Mohler MA, Apple T, Hébert CA, Valente AJ, et al. Red blood cells are a sink for interleukin-8, a leukocyte chemotaxin. J Clin Invest 1991;88:1362-9.
88. Tilg H, Pape D, Trehu E, Shapiro L, Atkins MB, Dinarello CA, et al. A method for the detection of erythrocyte-bound interleukin-8 in humans during interleukin-1 immunotherapy. J Immunol Methods 1993;163:253-8.
89. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993;268:12247-9.
90. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993;261:1182-4.
91. Horuk R, Zi-xuan W, Peiper SC, Hesselgesser J. Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line. J Biol Chem 1995;269:17730-3.
92. Zhao-hai L, Zi-xuan W, Horuk R, Hesselgesser J, Yan-chun L, Hadley TJ, et al. The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J Biol Chem 1995;270:26239-45.
93. Nichols ME, Rubinstein P, Barnwell J, Rodriguez de Cordoba S, Rosenfield RE. A new human blood group specificity defined by a murine monoclonal antibody. J Exp Med 1987; 166:776-85.
94. Peiper SC, Wang Z, Neote K, Martin AW, Showell HJ, Conklyn MJ, et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995;181:1311-7.
95. Rot A. Binding of neutrophil attractant/activation protein-1 (interleukin 8) to resident dermal cells. Cytokine 1992;4:347-52.
96. Kanayama N, Kajiwara Y, Goto J, El Maradny E, Maehara K, Andou K, et al. Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leukoc Biol 1995;57:129-34.
97. Sylvester I, Yoshimura T, Sticherling M, Schröder J-M, Ceska M, Peichl P, et al. Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest 1992;90:471-81.